Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 08, 2023

SELL
$38.82 - $54.59 $12,383 - $17,414
-319 Reduced 10.15%
2,823 $114,000
Q4 2022

Feb 01, 2023

SELL
$40.77 - $53.73 $2,772 - $3,653
-68 Reduced 2.12%
3,142 $146,000
Q2 2022

Aug 09, 2022

SELL
$38.13 - $76.93 $1,143 - $2,307
-30 Reduced 0.93%
3,210 $152,000
Q1 2022

Apr 21, 2022

BUY
$56.06 - $74.11 $23,377 - $30,903
417 Added 14.77%
3,240 $231,000
Q2 2020

Jul 28, 2020

BUY
$46.37 - $57.58 $82,167 - $102,031
1,772 Added 168.6%
2,823 $142,000
Q4 2019

Jan 21, 2020

BUY
$57.95 - $66.61 $19,760 - $22,714
341 Added 48.03%
1,051 $65,000
Q1 2019

Apr 29, 2019

BUY
$69.08 - $105.66 $2,210 - $3,381
32 Added 4.72%
710 $68,000
Q3 2018

Nov 09, 2018

BUY
$85.46 - $126.37 $11,024 - $16,301
129 Added 23.5%
678 $58,000
Q3 2017

Nov 08, 2017

BUY
$37.91 - $46.8 $20,812 - $25,693
549
549 $26,000

Others Institutions Holding ENTA

About ENANTA PHARMACEUTICALS INC


  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $177M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Zurcher Kantonalbank (Zurich Cantonalbank) Portfolio

Follow Zurcher Kantonalbank (Zurich Cantonalbank) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.